
Learn why FcγR binding assays are critical for understanding your antibody’s MoA and safety, and how comprehensive receptor panels support more confident biologics development, leading to quicker regulatory approval

Across the biopharmaceutical landscape, interest in molecular glues continues to grow.

San Diego, CA April 17th – 22nd

In early drug discovery, identifying potential safety liabilities as early as possible is essential to reducing attrition during development.

Our team would be very pleased to meet with you!

Visit us at Booth #400. Listen to Jennifer’s talk on “Mechanism-driven Cell-based Assays to Screen & Characterize Bi- & Multi-specific Antibodies”. View our 3 posters on ADCs, bi-specific antibodies, and agonistic antibodies / checkpoint receptor cell-based assays. Gain access to relevant resources and webpages.